Department of Clinical Sciences Lund, Pediatric Heart Center, Skåne University Hospital, Lund University, Lund, Sweden. Address: Barnhjärtcentrum mottagning, Skånes universitetssjukhus, Lasarettsgatan 48, 221 85, Lund, Sweden; Department of Biomedical Engineering, Lund University, Lund, Sweden. Address: Box 118, 221 00, Lund, Sweden.
Department of Clinical Sciences Lund, Clinical Physiology, Skåne University Hospital, Lund University, Lund, Sweden. Address: Box 177, 221 00, Lund, Sweden.
Comput Biol Med. 2024 Mar;171:108033. doi: 10.1016/j.compbiomed.2024.108033. Epub 2024 Feb 2.
Atrioventricular valve disease is a common cause of heart failure, and successful surgical or interventional outcomes are crucial. Patient-specific fluid-structure interaction (FSI) modeling may provide valuable insights into valve dynamics and guidance of valve repair strategies. However, lack of validation has kept FSI modeling from clinical implementation. Therefore, this study aims to validate FSI simulations against in vitro benchmarking data, based on clinically relevant parameters for evaluating heart valve disease.
An FSI model that mimics the left heart was developed. The domain included a deformable mitral valve of different stiffnesses run with different inlet velocities. Five different cases were simulated and compared to in vitro data based on the pressure difference across the valve, the valve opening, and the velocity in the flow domain.
The simulations underestimate the pressure difference across the valve by 6.8-14 % compared to catheter measurements. Evaluation of the valve opening showed an underprediction of 5.4-7.3 % when compared to cine MRI, 2D Echo, and 3D Echo data. Additionally, the simulated velocity through the valve showed a 7.9-8.4 % underprediction in relation to Doppler Echo measurements. Qualitative assessment of the velocity profile in the ventricle and the streamlines of the flow in the domain showed good agreement of the flow behavior.
Parameters relevant to the diagnosis of heart valve disease estimated by FSI simulations showed good agreement when compared to in vitro benchmarking data, with differences small enough not to affect the grading of heart valve disease. The FSI model is thus deemed good enough for further development toward patient-specific cases.
房室瓣疾病是心力衰竭的常见病因,手术或介入治疗的成功至关重要。基于患者的流固耦合(FSI)模型可以为瓣膜动力学提供有价值的见解,并为瓣膜修复策略提供指导。然而,由于缺乏验证,FSI 模型一直未能应用于临床。因此,本研究旨在基于评估心脏瓣膜疾病的临床相关参数,用体外基准数据验证 FSI 模拟。
开发了一种模拟左心的 FSI 模型。该模型域包含不同刚度的可变形二尖瓣,以不同的入口速度运行。模拟了五个不同的案例,并基于瓣膜跨压、瓣膜开口和流场速度与体外数据进行了比较。
与导管测量相比,模拟的瓣膜跨压低估了 6.8-14%。与电影 MRI、二维超声心动图和三维超声心动图数据相比,瓣膜开口的评估显示低估了 5.4-7.3%。此外,与多普勒超声心动图测量相比,通过瓣膜的模拟速度低估了 7.9-8.4%。对心室中的速度分布和域内流的流线进行定性评估表明,流场行为具有良好的一致性。
与体外基准数据相比,FSI 模拟估计的与心脏瓣膜疾病诊断相关的参数具有良好的一致性,差异小到不会影响心脏瓣膜疾病的分级。因此,该 FSI 模型足以进一步开发用于特定患者的病例。